MaxxCell: payments to doctors
Payments that named MaxxCell as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $65K
- Providers
- 198
- Transactions
- 283
- Average per transaction
- $229
The per-transaction average — $229 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 198 providers the average total is $328, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Royal Biologics | $45,865 | 70.6% |
| Royal Biologics, Inc. | $19,057 | 29.4% |